Navigation Links
NDA Partners Appoints Deb Koeneman as Partner in the Firm
Date:12/19/2018

NDA Partners Chairman Carl Peck, MD, announced today that Deb Koeneman, MS, former Scientific Reviewer and Compliance Officer at the FDA Center for Devices and Radiological Health (CDRH), has been appointed a Partner in the firm. Ms. Koeneman has worked with NDA Partners as an Expert Consultant since 2015, and she has more than 25 years of regulatory experience. In addition to her FDA career, she was formerly the Director of Regulatory Affairs at Silverleaf Medical Products (Vomaris Innovations) and Senior Director of Regulatory Affairs and Regulatory Compliance Manager at OrthoLogic Corporation (Capstone Therapeutics).

Ms. Koeneman has been consulting for medical device, pharmaceutical, and combination biologic/device/drug companies for over 12 years. She has extensive experience managing and directing regulatory and quality assurance departments and performing due diligence for early stage new molecular entity peptides, novel medical devices, and combination products. Her areas of expertise include development strategy, pathway to market, regulatory submissions, and compliance. Her career highlights include developing and implementing strategies regarding medical devices, combination products, IDEs, PMAs, INDs, and helping to transform a medical device company into a drug development company.

According to Dr. David Feigal, Manager of NDA Partners’ Medical Device Practice, “Ms. Koeneman’s expertise in development and regulatory strategy, regulatory submissions, and compliance have been highly valued by our clients, and her leadership as a Partner in the firm will play a critical role as we expand the product development services that we offer to our clients. We are very pleased to welcome her as a Partner in the firm.”

Ms. Koeneman earned a BSE in Biomedical Engineering and a MS in Bioengineering from Arizona State University. She currently serves as a guest lecturer on FDA-related regulatory topics at Arizona State University and as an industrial advisory board member at Grand Canyon University.

About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle@ndapartners.com

Read the full story at https://www.prweb.com/releases/nda_partners_appoints_deb_koeneman_as_partner_in_the_firm/prweb15990878.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. TGen and Riddell announce partnership for biomarker study of concussive injuries
2. The DOE Joint Genome Institute expands capabilities via new partnerships
3. NOAA, partners predict possible record-setting deadzone for Gulf of Mexico
4. Advance Research Associates Partners With MedNet Solutions
5. Transatlantic partnership to tackle neurodegenerative disease
6. Newly discovered bacterial partnership changes ocean chemistry
7. 4 projects awarded Discovery Transformation Grant funding by Minnesota Partnership
8. Genetics Society of America joins editorial partnership for CBE-Life Sciences Education
9. BioForce Nanosciences, Inc. Expands Its Global Market. New partnership with Acugenex Limited
10. Medbox Partners with Licensed Medical Cannabis Laboratory and Cultivation Center in Canada
11. BGI partners with Life Technologies to offer sequencing applications on ion torrent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2020)... ... 21, 2020 , ... Lifecycle Biotechnologies announces the new line of high purity powder ... based on their process requirements and accurately weighed to 0.001 of a gram. The new ... , Sugars , Carbohydrates , Phosphates , ...
(Date:1/8/2020)... Ariz. (PRWEB) , ... January 08, 2020 , ... ... therapies, is now offering complimentary overnight shipping to its nationwide practice network ... biologics, but also due to volume in its Network the biologics themselves are ...
(Date:1/2/2020)... , ... January 02, 2020 , ... ... semi-custom aqueous reagents, chemicals, and medias, as well as medical grade plastic products ... and tissue-based product manufacturers. , “We are excited to bring even more ...
Breaking Biology News(10 mins):
(Date:2/5/2020)... ... February 04, 2020 , ... Shoreline Biome , a ... strain level, has announced a new distribution partnership in Asia. , The distribution ... to companies and research organizations in China, Hong Kong, and Macau. , Gene ...
(Date:1/28/2020)... ... January 28, 2020 , ... Genedata, ... the release of Genedata Expressionist ® 13.5 at the 2020 WCBP ... Methods (MAM) for characterizing and monitoring the quality of biopharmaceuticals throughout their ...
(Date:1/24/2020)... ... January 24, 2020 , ... The ... in biotechnology, diagnostics, therapeutics, laboratory and clinical services during the first two decades ... the world. And as Slone Partners celebrates its 20th anniversary this ...
(Date:1/22/2020)... ... January 21, 2020 , ... COBO Technologies and Cardea ... The partners have agreed to co-develop and market a portfolio of CRISPR QC ... programs. Over the longer-term, the parties aim to develop a COBO branded QC ...
Breaking Biology Technology: